Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mixx Health & Wellness vs Queen RX

Mixx Health & Wellness
Graded #266

Lower grade

vs+3.5
Queen RX
Graded #192

Higher grade

The verdict

Queen RX takes it — 66.3/100 to 62.8/100.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMixx Health & Wellness +2
79
77
Dose & formulationQueen RX +17
40
57
Clinical oversightQueen RX +5
64
69
Labs & monitoringMixx Health & Wellness +10
63
53
FulfillmentQueen RX +5
70
75
Contract termsQueen RX +6
55
61
Mixx Health & Wellness · left barQueen RX · right bar

The numbers

MetricMixx Health & WellnessQueen RX
WeighScore62.8/10066.3/100
GradeCC
Scorecard rank#266#192
SemaglutideNot disclosed$100/mo (quarterly plan, compounded)
TirzepatideNot disclosedNot disclosed
Coverage44 states45 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Mixx Health & Wellness

Graded #266 · C

Strengths

  • 44 jurisdictions enumerated in the public FAQ — confirm eligibility before intake
  • Operating LLC disclosed: Mixx Health and Wellness LLC (Wyoming law)
  • Named pharmacy partner: Promise Pharmacy, Palm Harbor FL, (727) 772-0500
  • Named founder: Dr. James David Lawrence III, MD, with a public origin story
  • $0 consultation fee — free intake and follow-ups

Where it loses points

  • Both medications are compounded semaglutide and tirzepatide — not FDA-approved brand drugs
  • Dose-tier pricing not available — /pricing and /products pages returned 404
  • No LegitScript, PCAB, or BBB trust badges visible
  • Wyoming governing-law clause — disputes adjudicated under Wyoming law regardless of your state
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Queen RX

Graded #192 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard